Clinical Trial Update: Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by Yale University is evaluating a GLP-1 receptor agonist (GLP-1 analogue) as an anti-obesity treatment in people with Type 1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 1 Diabetes Mellitus

Drugs mentioned

• GLP-1 receptor agonist (GLP-1 analogue)

Snippet

Sponsor: Yale University | Conditions: Diabetes type1, Obesity | Phase 2 | Status: RECRUITING